Sitagliptin / Metformin hydrochloride Mylan Den Europæiske Union - dansk - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Kerendia Den Europæiske Union - dansk - EMA (European Medicines Agency)

kerendia

bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - agenter, der virker på renin-angiotensinsystemet - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.

Azalia 75 mikrogram filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

azalia 75 mikrogram filmovertrukne tabletter

gedeon richter plc. - desogestrel - filmovertrukne tabletter - 75 mikrogram

Diamilla 75 mikrogram filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diamilla 75 mikrogram filmovertrukne tabletter

actavis group ptc ehf. - desogestrel - filmovertrukne tabletter - 75 mikrogram

Nacrez 75 mikrogram filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nacrez 75 mikrogram filmovertrukne tabletter

theramex ireland limited - desogestrel - filmovertrukne tabletter - 75 mikrogram

Desirett 75 mikrogram filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

desirett 75 mikrogram filmovertrukne tabletter

exeltis healthcare s.l - desogestrel - filmovertrukne tabletter - 75 mikrogram

Lopinavir/Ritonavir Mylan Den Europæiske Union - dansk - EMA (European Medicines Agency)

lopinavir/ritonavir mylan

mylan pharmaceuticals limited - lopinavir, ritonavir - hiv infektioner - antivirale midler til systemisk anvendelse - lopinavir/ritonavir angives i kombination med andre antiretrovirale lægemidler til behandling af human immundefekt virus (hiv-1) inficeret voksne, unge og børn over 2 år. valget af lopinavir/ritonavir til at behandle proteasehæmmer oplevet hiv-1-inficerede patienter bør være baseret på individuelle viral resistens test og historie behandling af patienter.